Akari Therapeutics ADR (NQ: AKTX )
1.650 USD -0.010 (-0.60%) Streaming Delayed Price Updated: 1:17 PM EST, Dec 2, 2021 Add to My Watchlist
All news about Akari Therapeutics ADR
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 17, 2021
Gainers Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 7.36% to $35.0 during Wednesday's after-market session. The ...
Akari Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Clinical Progress
September 22, 2021
Akari Therapeutics to Present Its Phase III Plans for Nomacopan in Patients with Bullous Pemphigoid at the 2021 International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium
September 10, 2021
Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference
September 07, 2021
Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The ...
Akari Therapeutics Reports Q1 2021 Financial Results and Highlights Recent Clinical Progress
June 29, 2021
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The ...
Akari Therapeutics' Nomacopan Secures Expediated Review Tag For Blistering Skin Disorder
April 28, 2021
TheFDA has granted Fast Track designationtoAkari Therapeutics Plc's(NASDAQ:AKTX) nomacopan to treat ...
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market ...
Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for the Treatment of Bullous Pemphigoid
April 28, 2021
Akari Therapeutics Announces Poster Presentation of Phase II Bullous Pemphigoid Disease and Phase III Trial Design at American Academy of Dermatology Association Virtual Meeting Experience
April 22, 2021
Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
April 20, 2021
Gainers Obalon Therapeutics (NASDAQ:OBLN) shares moved upwards by 6.04% to $2.63 during Monday's after-market session. At the ...
25 Stocks Moving in Tuesday's Pre-Market Session
April 13, 2021
Gainers Dragon Victory International Limited (NASDAQ: LYL) rose 52.1% to $2.16 in pre-market trading after dropping around 8% on ...
The FDA hasopened the investigational new drug applicationfor Phase 3 trial forAkari Therapeutics ...
42 Stocks Moving In Monday's Mid-Day Session
April 12, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that ...
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Bullous Pemphigoid (BP)
April 12, 2021
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 05, 2021
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 102.76% to $5.86 during Friday's pre-market ...
Gainers Fulgent Genetics (NASDAQ:FLGT) stock moved upwards by 29.19% to $110.5 during Thursday's after-market session. This ...
Akari Therapeutics Announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) for Nomacopan in Trauma
March 04, 2021
Study of porcine model of blast injury and haemorrhagic shock underway with USAISR as part of the development of a clinical path for the use of nomacopan to treat trauma
Akari Therapeutics Plc(NASDAQ:AKTX)announces new datafrom PASylated nomacopan published in the journal ...
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
February 25, 2021
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
12 Health Care Stocks Moving In Monday's After-Market Session
February 22, 2021
Gainers Insulet (NASDAQ:PODD) stock moved upwards by 15.87% to $297.22 during Monday's after-market session. Today's trading ...
80 Biggest Movers From Friday
February 22, 2021
Gainers Energous Corporation (NASDAQ: WATT) shares surged 94.4% to close at $7.23 on Friday following Bloomberg report Apple is ...
Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease
February 01, 2021
101 Biggest Movers From Yesterday
January 29, 2021
Gainers New Concept Energy, Inc. (NYSE: GBR) shares jumped 959.3% to close at $25.00 on Thursday. Marine Petroleum Trust ...
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...